Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
1993.
Clozapine, cancer, and schizophrenia.
American Journal of Psychiatry,
Vol. 150,
Issue. 10,
p.
1562.
1993.
Atropinism may precipitate neuroleptic malignant syndrome during treatment with clozapine [published erratum appears in Am J Psychiatry 1993 Dec;150(12):1910].
American Journal of Psychiatry,
Vol. 150,
Issue. 10,
p.
1561b.
Mortensen, Preben Bo
1994.
The occurence of cancer in first admitted schizophrenic patients.
Schizophrenia Research,
Vol. 12,
Issue. 3,
p.
185.
McDonald, C.
and
Sheppard, N.
1996.
Smoking in chronic psychiatric illness: is it worth it?.
Psychiatric Bulletin,
Vol. 20,
Issue. 9,
p.
533.
Casadebaig, F
Philippe, A
Guillaud-Bataille, JM
Gausset, MF
Quemada, N
and
Terra, JL
1997.
Schizophrenic patients: physical health and access to somatic care.
European Psychiatry,
Vol. 12,
Issue. 6,
p.
289.
Yovel, Galit
Sirota, Pinkhas
Mazeh, Doron
Shakhar, Guy
Rosenne, Ella
and
Ben-Eliyahu, Shamgar
2000.
Higher Natural Killer Cell Activity in Schizophrenic Patients: The Impact of Serum Factors, Medication, and Smoking.
Brain, Behavior, and Immunity,
Vol. 14,
Issue. 3,
p.
153.
McDonald, C.
2000.
Cigarette smoking in patients with schizophrenia.
British Journal of Psychiatry,
Vol. 176,
Issue. 6,
p.
596.
Catts, Vibeke Sørensen
and
Catts, Stanley Victor
2000.
Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene?.
Schizophrenia Research,
Vol. 41,
Issue. 3,
p.
405.
Mulvihill, J. J.
2000.
Genes and Resistance to Disease.
p.
169.
Cohen, Mary E.
Dembling, Bruce
and
Schorling, John B.
2002.
The association between schizophrenia and cancer: a population-based mortality study.
Schizophrenia Research,
Vol. 57,
Issue. 2-3,
p.
139.
Teunis, Marc A.T.
Kavelaars, Annemieke
Voest, Emile
Bakker, Joost M.
Ellenbroek, Bart. A.
Cools, Alexander R.
and
Heijnen, Cobi J.
2002.
Reduced tumor growth, experimental metastasis formation, and angiogenesis in rats with a hyperreactive dopaminergic system.
The FASEB Journal,
Vol. 16,
Issue. 11,
p.
1465.
Dickey, Barbara
Normand, Sharon-Lise T.
Weiss, Roger D.
Drake, Robert E.
and
Azeni, Hocine
2002.
Medical Morbidity, Mental Illness, and Substance Use Disorders.
Psychiatric Services,
Vol. 53,
Issue. 7,
p.
861.
Sanders, Virginia M.
and
Straub, Rainer H.
2002.
Norepinephrine, the β-Adrenergic Receptor, and Immunity.
Brain, Behavior, and Immunity,
Vol. 16,
Issue. 4,
p.
290.
Carrillo, Juan Antonio
Herráiz, Angustias G.
Ramos, Sara Isabel
Gervasini, Guillermo
Vizcaíno, Sonia
and
Benítez, Julio
2003.
Role of the Smoking-Induced Cytochrome P450 (CYP)1A2 and Polymorphic CYP2D6 in Steady-State Concentration of Olanzapine.
Journal of Clinical Psychopharmacology,
Vol. 23,
Issue. 2,
p.
119.
Oksbjerg Dalton, Susanne
Munk Laursen, Thomas
Mellemkjær, Lene
Johansen, Christoffer
and
Mortensen, Preben B.
2003.
Schizophrenia and the risk for breast cancer.
Schizophrenia Research,
Vol. 62,
Issue. 1-2,
p.
89.
Dalton, Susanne Oksbjerg
Laursen, Thomas Munk
Mellemkjær, Lene
Johansen, Christoffer
and
Mortensen, Preben Bo
2004.
Risk for Cancer in Parents of Patients With Schizophrenia.
American Journal of Psychiatry,
Vol. 161,
Issue. 5,
p.
903.
Carney, Caroline P.
Woolson, Robert F.
Jones, Laura
Noyes, Russell
and
Doebbeling, Bradley N.
2004.
Occurrence of Cancer Among People With Mental Health Claims in an Insured Population.
Psychosomatic Medicine,
Vol. 66,
Issue. 5,
p.
735.
Teunis, Marc A.T
Heijnen, Cobi J
Cools, Alexander R
and
Kavelaars, Annemieke
2004.
Reduced splenic natural killer cell activity in rats with a hyperreactive dopaminergic system.
Psychoneuroendocrinology,
Vol. 29,
Issue. 8,
p.
1058.
Foster, Harold D
and
Hoffer, Abram
2004.
Schizophrenia and cancer: the adrenochrome balanced morphism.
Medical Hypotheses,
Vol. 62,
Issue. 3,
p.
415.
Grinshpoon, Alexander
Barchana, Micha
Ponizovsky, Alexander
Lipshitz, Irena
Nahon, Daniella
Tal, Orna
Weizman, Abraham
and
Levav, Itzhak
2005.
Cancer in schizophrenia: is the risk higher or lower?.
Schizophrenia Research,
Vol. 73,
Issue. 2-3,
p.
333.
eLetters
No eLetters have been published for this article.